Shandong Jincheng Pharmaceutical Group Third Quarter 2024 Earnings: EPS: CN¥0.056 (vs CN¥0.08 in 3Q 2023)

Simply Wall St · 10/25 22:12

Shandong Jincheng Pharmaceutical Group (SZSE:300233) Third Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥756.7m (down 12% from 3Q 2023).
  • Net income: CN¥20.5m (down 34% from 3Q 2023).
  • Profit margin: 2.7% (down from 3.6% in 3Q 2023). The decrease in margin was driven by lower revenue.
  • EPS: CN¥0.056 (down from CN¥0.08 in 3Q 2023).
earnings-and-revenue-history
SZSE:300233 Earnings and Revenue History October 25th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Shandong Jincheng Pharmaceutical Group shares are up 3.2% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Shandong Jincheng Pharmaceutical Group, and understanding it should be part of your investment process.